|
109 Companies |
|
17 Products |
|
17 Products |
|
10 Mechanisms of Action |
|
928 Trials |
|
100297 News |
|
| «12...17531754175517561757175817591760176117621763...17681769» |
- Trial primary completion date: Feeling of Being in Control of One's Own Action (clinicaltrials.gov) - Sep 16, 2016
P=N/A, N=370, Recruiting, Sponsor: University Hospital, Strasbourg, France
Trial primary completion date: Dec 2018 --> Dec 2017
- || New P3 trial: Oral ketamine for treating depression Orale ketamine als aanvullende behandeling bij pati (EUDRACT) - Sep 16, 2016
P3, N=128, Ongoing, Sponsor: University Medical Centre Groningen
- escitalopram / Generic mfg.
Trial completion: Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders (clinicaltrials.gov) - Sep 15, 2016
P4, N=289, Completed, Sponsor: Medical University of Vienna
Trial primary completion date: Dec 2018 --> Dec 2017 Recruiting --> Completed
- Enrollment closed: Balancing Everyday Life - A Lifestyle Intervention for People With Psychiatric Disorders (clinicaltrials.gov) - Sep 13, 2016
P=N/A, N=240, Active, not recruiting, Sponsor: Lund University
Recruiting --> Completed Recruiting --> Active, not recruiting
- aripiprazole / Generic mfg., risperidone / Generic mfg.
New trial, IO biomarker: PAFIP_TLR: Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients (clinicaltrials.gov) - Sep 13, 2016
P=N/A, N=150, Enrolling by invitation, Sponsor: Fundaci
- New trial: Metabolic and Neurofunctional Responses to Breakfasts (clinicaltrials.gov) - Sep 13, 2016
P=N/A, N=12, Completed, Sponsor: Ospedale San Donato
- New trial: ONCODEFI: Awareness on Cancer in Persons With Intellectual Disabilities (clinicaltrials.gov) - Sep 13, 2016
P=N/A, N=800, Recruiting, Sponsor: Centre Hospitalier Universitaire de N?mes
- New trial: Evaluate the Value of Telehomecare for Mental Health (clinicaltrials.gov) - Sep 12, 2016
P=N/A, N=1000, Recruiting, Sponsor: Women's College Hospital
- New P1 trial: Effects of CO-OP Approach on Activity and Participation of Brazilian Children With Developmental Coordination Disorder (clinicaltrials.gov) - Sep 9, 2016
P1, N=20, Recruiting, Sponsor: Federal University of Minas Gerais
- Trial primary completion date: RBD6YR: RBD Longitudinal as Prognostic for PD (clinicaltrials.gov) - Sep 8, 2016
P=N/A, N=240, Recruiting, Sponsor: The University of Texas Health Science Center, Houston
Recruiting --> Active, not recruiting Trial primary completion date: Jun 2016 --> Jun 2017
- New trial: Neurobiologic, Immunologic, and Rheumatologic Markers in Youth With PANS (clinicaltrials.gov) - Sep 6, 2016
P=N/A, N=500, Recruiting, Sponsor: Stanford University
- Biomarker, New trial: NGS-DI: Targeted Next Generation Sequencing and Intellectual Disability (clinicaltrials.gov) - Sep 5, 2016
P=N/A, N=40, Active, not recruiting, Sponsor: Central Hospital, Nancy, France
- New trial: DAPHNE Scale Validation in Frontotemporal Lobar Degeneration (clinicaltrials.gov) - Sep 5, 2016
P=N/A, N=100, Recruiting, Sponsor: Nantes University Hospital
- Trial completion, Enrollment change: Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients (clinicaltrials.gov) - Sep 2, 2016
P=N/A, N=139, Completed, Sponsor: Treatment Research Institute
Trial primary completion date: Jun 2016 --> Jun 2017 N=175 --> 139 | Active, not recruiting --> Completed
- Enrollment open: Behavioral Expressions in Alzheimer's Disease (clinicaltrials.gov) - Sep 2, 2016
P4, N=30, Recruiting, Sponsor: University of Florida
N=175 --> 139 | Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- New trial: Mental Healthcare in Older Adults With Schizophrenia (clinicaltrials.gov) - Aug 31, 2016
P=N/A, N=685, Active, not recruiting, Sponsor: CHU de Reims
- Trial primary completion date: The Oral Accessibility Spatula (Spatule SAB) (clinicaltrials.gov) - Aug 26, 2016
P=N/A, N=200, Recruiting, Sponsor: Centre Hospitalier R
Not yet recruiting --> Recruiting Trial primary completion date: Mar 2018 --> Sep 2017
- New trial: CNV-Seq: Various Type of Genetic Events in Patients With Intellectual Disability (clinicaltrials.gov) - Aug 25, 2016
P=N/A, N=30, Not yet recruiting, Sponsor: University Hospital, Strasbourg, France
- Trial primary completion date: Effects of Delta-9-THC and Iomazenil in Healthy Humans (clinicaltrials.gov) - Aug 24, 2016
P1, N=60, Active, not recruiting, Sponsor: Yale University
Trial primary completion date: Mar 2018 --> Sep 2017 Trial primary completion date: Jun 2016 --> Jun 2017
- Enrollment open: Integrated Collaborative Care Teams for Youth With Mental Health and/or Addiction Challenges (YouthCan IMPACT) (clinicaltrials.gov) - Aug 23, 2016
P=N/A, N=500, Recruiting, Sponsor: Centre for Addiction and Mental Health
Trial primary completion date: Jun 2016 --> Jun 2017 Not yet recruiting --> Recruiting
- ||||| paroxetine / Generic mfg.
New P4 trial: Study to evaluate the efficacy and safety of Paxil (EUDRACT) - Aug 19, 2016
P4, N=319, , Sponsor: GlaxoSmithKline Research & Development
- ||||| nelotanserin (RVT-102) / Roivant
New P2 trial: Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder (clinicaltrials.gov) - Aug 19, 2016
P2, N=80, Enrolling by invitation, Sponsor: Axovant Sciences Ltd.
- Enrollment change: TMS for the Investigation of Brain Plasticity in Autism Spectrum Disorders (clinicaltrials.gov) - Aug 17, 2016
P=N/A, N=185, Recruiting, Sponsor: Children's Hospital Boston
Not yet recruiting --> Recruiting N=37 --> 185
- New trial: PAXGBGEE: Impact of PAX Good Behavior Game on Elementary School Students in Estonia (clinicaltrials.gov) - Aug 12, 2016
P=N/A, N=1152, Enrolling by invitation, Sponsor: National Institute for Health Development, Estonia
- New trial: SHD-DI: Molecular Diagnosis of Syndromic or Isolated Severe Intellectual Disability Using Whole Exome Sequencing : a Pilot Study (clinicaltrials.gov) - Aug 11, 2016
P=N/A, N=17, Not yet recruiting, Sponsor: Centre Hospitalier Universitaire de Besancon
- Trial primary completion date: Enhancing Genomic Laboratory Reports to Enhance Communication and Empower Patients (clinicaltrials.gov) - Aug 10, 2016
P=N/A, N=80, Enrolling by invitation, Sponsor: Geisinger Clinic
N=37 --> 185 Trial primary completion date: Sep 2016 --> Dec 2016
- Trial completion, Enrollment change: AHCM: Addiction Housing Case Management for Homeless Veterans (clinicaltrials.gov) - Aug 10, 2016
P=N/A, N=181, Completed, Sponsor: VA Office of Research and Development
Trial primary completion date: Sep 2016 --> Dec 2016 Active, not recruiting --> Completed | N=400 --> 181
- Trial primary completion date: Study of Structural Imaging (clinicaltrials.gov) - Aug 8, 2016
P=N/A, N=250, Recruiting, Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Active, not recruiting --> Completed | N=400 --> 181 Trial primary completion date: Sep 2020 --> Jun 2020
- New trial: EXERTMG: Impact of Aerobic Exercise on Metabolic Syndrome, Neurocognition and Empowerment in Individuals With Mental Disorders (clinicaltrials.gov) - Aug 8, 2016
P=N/A, N=50, Recruiting, Sponsor: Fundaci
- New trial: REDAP: Evaluative Research in the Process of Implementation of an Alternative Device to Hospitalization for People Homeless With Severe Psychiatric Disorders (clinicaltrials.gov) - Aug 5, 2016
P=N/A, N=30, Not yet recruiting, Sponsor: Assistance Publique Hopitaux De Marseille
- New trial: VEPSY: Effectiveness Accompaniment Perioperative Patients With Psychiatric Illness on the Lives Perioperative (clinicaltrials.gov) - Aug 5, 2016
P=N/A, N=88, Not yet recruiting, Sponsor: Assistance Publique Hopitaux De Marseille
- New trial: XLMR: Clinical Phenotyping and Characterization of Neural Networks and Cognitive Processes Involved in Mental Retardation X-linked (clinicaltrials.gov) - Aug 4, 2016
P=N/A, N=290, Recruiting, Sponsor: Hospices Civils de Lyon
- New trial: Steps to Effective Problem Solving in Group Homes (clinicaltrials.gov) - Aug 4, 2016
P=N/A, N=288, Not yet recruiting, Sponsor: Rush University Medical Center
- ||| Trial completion, Enrollment change: VillageWhere: Using Mobile Technology to Enhance Multisystemic Therapy (MST) Outcomes (clinicaltrials.gov) - Aug 3, 2016
P1, N=83, Completed, Sponsor: Evidence-Based Practice Institute, Seattle, WA
Trial primary completion date: Sep 2020 --> Jun 2020 Enrolling by invitation --> Completed | N=50 --> 83
- ||| Enrollment open: Fingerprinting of Impulsivity (clinicaltrials.gov) - Aug 2, 2016
P=N/A, N=240, Recruiting, Sponsor: Boehringer Ingelheim
Enrolling by invitation --> Completed | N=50 --> 83 Not yet recruiting --> Recruiting
- Enrollment closed, Enrollment change: Violin: Managing Patient Aggression in Mental Health Services (clinicaltrials.gov) - Aug 2, 2016
P=N/A, N=28, Active, not recruiting, Sponsor: University of Turku
Not yet recruiting --> Recruiting Not yet recruiting --> Active, not recruiting | N=15 --> 28
- Enrollment open, Trial initiation date: Phase II Motivational Interviewing: An Experiential Online Training Tool (clinicaltrials.gov) - Jul 28, 2016
P2, N=3780, Recruiting, Sponsor: Center for Social Innovation, Massachusetts
Not yet recruiting --> Active, not recruiting | N=15 --> 28 Not yet recruiting --> Recruiting | Initiation date: Sep 2015 --> Mar 2016
- Trial completion: Genetic Predictors of Lithium Response in Bipolar Disorder (clinicaltrials.gov) - Jul 28, 2016
P=N/A, N=130, Completed, Sponsor: VA Office of Research and Development
Not yet recruiting --> Recruiting | Initiation date: Sep 2015 --> Mar 2016 Recruiting --> Completed
- New trial: EnBiGen: Endophenotype Characterization of a Family Psychiatric Disorder (clinicaltrials.gov) - Jul 27, 2016
P=N/A, N=29, Recruiting, Sponsor: University Hospital, Grenoble
- NN1213 / Novo Nordisk
Trial completion, Enrollment change: Brain Changes in Children and Adolescents With Behavioral Problems (clinicaltrials.gov) - Jul 25, 2016
P=N/A, N=318, Completed, Sponsor: National Institute of Mental Health (NIMH)
Recruiting --> Completed Recruiting --> Completed | N=640 --> 318
- trazodone ER / Generic mfg.
Enrollment closed, Trial primary completion date: Sequenced Therapies for Comorbid and Primary Insomnias (clinicaltrials.gov) - Jul 23, 2016
P4, N=224, Active, not recruiting, Sponsor: Jack Edinger, PhD
Recruiting --> Completed | N=640 --> 318 Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2016 --> Sep 2016
- | Enrollment open: STIM'ZO : Examining tDCS as an add-on Treatment for Persistent Symptoms in Schizophrenia (clinicaltrials.gov) - Jul 23, 2016
P3, N=138, Recruiting, Sponsor: Hospices Civils de Lyon
Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2016 --> Sep 2016 Not yet recruiting --> Recruiting
- New trial: TMS for the Investigation of Brain Plasticity in Autism Spectrum Disorders (clinicaltrials.gov) - Jul 19, 2016
P=N/A, N=37, Recruiting, Sponsor: Children's Hospital Boston
- Biomarker, Trial primary completion date: PANS - A Detailed Study of the Patients, Their Symptoms, Biomarkers and Treatment Offered in a Scandinavian Cohort (clinicaltrials.gov) - Jul 19, 2016
P=N/A, N=185, Recruiting, Sponsor: Karolinska Institutet
Not yet recruiting --> Recruiting Trial primary completion date: Jun 2016 --> Dec 2016
- Circadin (melatonin prolonged release) / Lundbeck, Neurim, Flynn Pharma, Grupo Insud, Biocodex, Kuhnil Pharma
New P4 trial: Effect of Slow-release Melatonin (Circadin (clinicaltrials.gov) - Jul 19, 2016
P4, N=30, Recruiting, Sponsor: Seoul National University Hospital
- New trial: Integrated Collaborative Care Teams for Youth With Mental Health and/or Addiction Challenges (YouthCan IMPACT) (clinicaltrials.gov) - Jul 18, 2016
P=N/A, N=500, Not yet recruiting, Sponsor: Centre for Addiction and Mental Health
- New trial: NOHA-PSY: Assessment of the Prevalence of Major Psychiatric Disorders in a Cohort of Women With Clinical Criteria Corresponding to Pure, Abortive-form, Obstetrical, Antiphospholipid Syndrome (clinicaltrials.gov) - Jul 14, 2016
P=N/A, N=1592, Completed, Sponsor: Centre Hospitalier Universitaire de N?mes
- New trial: MP-TCSP-IRMf: Exploration of the Reward System by Functional MRI in Parkinson's Disease Patients With and Without REM Sleep Behavior Disorder (clinicaltrials.gov) - Jul 6, 2016
P=N/A, N=75, Recruiting, Sponsor: University Hospital, Clermont-Ferrand
- | oxytocin / Generic mfg.
New P2 trial: Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders (clinicaltrials.gov) - Jul 6, 2016
P2, N=60, Not yet recruiting, Sponsor: University of Nebraska
- ||||||| Rexulti (brexpiprazole) / Lundbeck, Otsuka
Trial completion, Trial primary completion date: Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress (clinicaltrials.gov) - Jul 5, 2016
P3, N=837, Completed, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Trial primary completion date: Jun 2016 --> Dec 2016 Active, not recruiting --> Completed | Trial primary completion date: Aug 2016 --> Apr 2016